Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Network Meta-Analysis.

Authors:
Chen Y; Li F; Luo J; Chen J; Luo P and 1 more

Journal:
Can Respir J

Publication Year: 2021

DOI:
10.1155/2021/1626971

PMCID:
PMC8426079

PMID:
34512819

Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"This work was supported by the National Natural Science Foundation of China under grant award number 81870233."

Evidence found in paper:

"This study, including its inclusion and exclusion criteria, literature sources and searches, data extraction, quality assessment and risk of bias assessment, and data synthesis and analysis, was conducted under the Cochrane criteria [] and the PRISMA guidelines [, ]. Items for the systematic review and NMA were identified based on an a priori protocol (PROSPERO: CRD42020173765) []. Methods: We searched PubMed, EMBASE, Web of Science, the Cochrane Central Register, https://clinicaltrials.gov, and who.int/trialsearch/, for relevant RCTs published up to January 2020. In addition to traditional meta-analysis, we also performed NMA in our systematic review, as deployed in a previous protocol (PROSPERO: CRD42020173765). "

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025